NK cells in many solid tumors including breast, lung, and liver cancers show increased expression of NKG2A, and likewise HLA-E is frequently increased in melanoma and cancers of the lung, kidney, liver, prostate, and colon [27, 29]. This evidence concerns the gene KLRC1 and melanoma.